Suncorp (ASX:SUN) has sold New Zealand life business to Resolution Life for NZ$410M.

Imugene's (ASX:IMU) oncolytic virotherapy CF33 has secured a key patent in China.

And the ACCC has greenlit Cochlear's (ASX:COH) plan to buy Oticon's implant business.